Literature DB >> 20045447

Mu and kappa opioid receptor expression in the mediobasal hypothalamus and effectiveness of selective antagonists on prolactin release during lactation.

M Tavakoli-Nezhad1, L A Arbogast.   

Abstract

Endogenous opioid peptides are involved in prolactin release during lactation, in part by decreasing tuberoinfundibular dopaminergic (TIDA) neuronal activity. Both mu (mu) and kappa (kappa) opioid receptors have a role in the suckling-induced prolactin rise after 4-5 h up deprivation. The aim of this study was to investigate effects of mu opioid receptor antagonist, beta-funaltrexamine (beta-FNA), and kappa opioid receptor antagonist, nor-binaltorphimine (nor-BNI), on prolactin secretion and TIDA neuronal activity in lactating rats after 18 h pup deprivation. After 4 h separation from pups, the suckling-induced prolactin rise was abolished by 16 microg nor-BNI and 5 microg beta-FNA, coincident with increased dihydroxyphenylacetic acid (DOPAC):dopamine ratio in the stalk-median eminence (SME). However, after 18 h pups separation, these same doses of nor-BNI and beta-FNA did not alter the prolactin surge or DOPAC:dopamine ratios in the SME. Higher doses of nor-BNI (32 microg) and beta-FNA (10 microg) were required to inhibit suckling-induced prolactin secretion. beta-FNA (10 microg) increased the DOPAC:dopamine ratio in the SME, whereas nor-BNI (32 microg) treatment had no effect. The mu and kappa opioid receptor mRNA levels in the mediobasal hypothalamus were similar to suckled control rats after 4 h pup deprivation, but increased 1.4-fold after 18 h pup deprivation. These data support involvement of endogenous opioidergic systems in the suckling-induced prolactin rise after a prolonged (18 h) period of pup deprivation, as well as the shorter (4 h) pup deprivation period previously reported. Suppression of TIDA neuronal activity likely played a part in mu opioid receptor input to the suckling-induced prolactin rise after both 4 h and 18 h separation, whereas non-dopaminergic input was implicated with kappa opioid receptors after 18 h pup deprivation. Increased mu and kappa opioid receptors gene expression in the mediobasal hypothalamus may contribute to reduced effectiveness of opioid receptor antagonists to block suckling-induced prolactin release after 18 h pup deprivation. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045447      PMCID: PMC2824054          DOI: 10.1016/j.neuroscience.2009.12.066

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  49 in total

Review 1.  Dopamine as a prolactin (PRL) inhibitor.

Authors:  N Ben-Jonathan; R Hnasko
Journal:  Endocr Rev       Date:  2001-12       Impact factor: 19.871

Review 2.  Behavioural significance of prolactin signalling in the central nervous system during pregnancy and lactation.

Authors:  David R Grattan
Journal:  Reproduction       Date:  2002-04       Impact factor: 3.906

Review 3.  Real-time PCR for mRNA quantitation.

Authors:  Marisa L Wong; Juan F Medrano
Journal:  Biotechniques       Date:  2005-07       Impact factor: 1.993

4.  Immunoneutralization of endogenous opioid peptides prevents the suckling-induced prolactin increase and the inhibition of tuberoinfundibular dopaminergic neurons.

Authors:  P Callahan; S Klosterman; D Prunty; J Tompkins; J Janik
Journal:  Neuroendocrinology       Date:  2000-04       Impact factor: 4.914

5.  Endogenous opioid peptides contribute to suckling-induced prolactin release by suppressing tyrosine hydroxylase activity and messenger ribonucleic acid levels in tuberoinfundibular dopaminergic neurons.

Authors:  L A Arbogast; J L Voogt
Journal:  Endocrinology       Date:  1998-06       Impact factor: 4.736

Review 6.  Acute opioid receptor desensitization and tolerance: is there a link?

Authors:  S L Borgland
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-03       Impact factor: 2.557

Review 7.  Neuroendocrine actions and regulation of hypothalamic neuropeptide Y during lactation.

Authors:  W R Crowley; G Ramoz; R Torto; K A Keefe; J J Wang; S P Kalra
Journal:  Peptides       Date:  2007-01-22       Impact factor: 3.750

8.  Orphanin FQ/nociceptin is a physiological regulator of prolactin secretion in female rats.

Authors:  Matthew Chesterfield; James Janik; Emily Murphree; Courtney Lynn; Erin Schmidt; Phyllis Callahan
Journal:  Endocrinology       Date:  2006-08-03       Impact factor: 4.736

9.  Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding.

Authors:  C R Neal; A Mansour; R Reinscheid; H P Nothacker; O Civelli; H Akil; S J Watson
Journal:  J Comp Neurol       Date:  1999-10-04       Impact factor: 3.215

Review 10.  Lactogenic hormone regulation of maternal behavior.

Authors:  P E Mann; R S Bridges
Journal:  Prog Brain Res       Date:  2001       Impact factor: 2.453

View more
  4 in total

1.  Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues.

Authors:  Heather R Christensen; Michael K Murawsky; Nelson D Horseman; Tara A Willson; Karen A Gregerson
Journal:  Endocrinology       Date:  2013-09-12       Impact factor: 4.736

2.  Promoting effects of isobavachin on neurogenesis of mouse embryonic stem cells were associated with protein prenylation.

Authors:  Dan-yin Wang; Yu-zhe Hu; Si-si Kong; Yong-ping Yu; Dan-yan Zhu; Yi-jia Lou
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

3.  Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: pharmacological evidence of activation by morphine.

Authors:  Samuel S Pappas; Tom Kennedy; John L Goudreau; Keith J Lookingland
Journal:  Neuropharmacology       Date:  2011-05-13       Impact factor: 5.250

Review 4.  Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.

Authors:  Kaitlin C Reeves; Nikhil Shah; Braulio Muñoz; Brady K Atwood
Journal:  Front Mol Neurosci       Date:  2022-06-15       Impact factor: 6.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.